Crown Aesthetics (Crown Laboratories) Acquires Select Assets from Healeon LLC (Bimini Health Tech)

Bimini Health Tech Acquires Healeon Medical, Inc.

June 16, 2020

Medical Devices

Bimini Health Tech has acquired Healeon Medical, Inc., adding Healeon's point-of-care PRP and adipose tissue processing medical devices to Bimini's regenerative medicine portfolio. The purchase expands Bimini's autologous product offering and brings Healeon's commercial PRP products and adipose pipeline under Bimini's global commercialization capabilities.

Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets

May 24, 2022

Medical Devices

Crown Laboratories has acquired the global, aesthetics-focused assets of Eclipse Medcorp, LLC, expanding Crown's aesthetics product portfolio and integrating Eclipse's devices into its Aesthetics business unit. The deal aims to broaden Crown's product offerings to aesthetics providers domestically and internationally and preserve service and medical-education support for Eclipse customers under Crown.

Crown Laboratories Acquires Revance Therapeutics

August 12, 2024

Biotechnology

Crown Laboratories, a Hildred Capital portfolio company, completed the acquisition of Revance Therapeutics through a cash tender offer that expired February 4, 2025; the transaction closed on February 6, 2025 and Revance will be delisted from Nasdaq. The deal brings together Crown's skincare and consumer brands with Revance's DAXXIFY, RHA dermal fillers and other aesthetics/therapeutic offerings to expand product portfolio and commercialization capabilities across medical, retail and e-commerce channels.

LPL Financial Acquires Crown Capital Securities' Wealth Management Business

May 8, 2024

Wealth Management

LPL Financial has closed its acquisition of the wealth management business of Crown Capital Securities, L.P., a full-service broker-dealer and registered investment advisor based in Orange County, California. Approximately 125 advisors representing about $1.3 billion of brokerage and advisory assets have been onboarded to LPL as of May 8, 2024, with roughly $3.7 billion expected to transfer in the coming months.

The Pritzker Organization Makes Growth Investment in Crown Health Care Laundry Services

March 8, 2021

Healthcare Services

The Pritzker Organization has made a growth investment in Crown Health Care Laundry Services, with affiliates of Quilvest Capital Partners selling their majority interests. Blenheim LP and Crown management remain significant shareholders; financial terms were not disclosed. The investment is intended to support Crown's next phase of growth, including expanding its customer base, geographic presence and facility network.

Astellas Pharma Acquires Propella Therapeutics

November 15, 2023

Biotechnology

Astellas Pharma, through its U.S. subsidiary Astellas US Holding, agreed to acquire privately held biopharmaceutical company Propella Therapeutics for approximately US$175 million. The acquisition gives Astellas ownership of PRL-02, a next-generation long-acting abiraterone prodrug for prostate cancer currently in Phase 1, and is expected to close within Astellas' fiscal year 2023 (ending March 31, 2024).